Xenon Pharmaceuticals Inc (XENE)
42.05
-0.67
(-1.57%)
USD |
NASDAQ |
Dec 09, 16:00
42.05
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap: 3.206B for Dec. 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| December 09, 2024 | 3.206B |
| December 06, 2024 | 3.257B |
| December 05, 2024 | 3.157B |
| December 04, 2024 | 3.228B |
| December 03, 2024 | 3.202B |
| December 02, 2024 | 3.211B |
| November 29, 2024 | 3.250B |
| November 27, 2024 | 3.290B |
| November 26, 2024 | 3.236B |
| November 25, 2024 | 3.178B |
| November 22, 2024 | 3.137B |
| November 21, 2024 | 3.034B |
| November 20, 2024 | 2.999B |
| November 19, 2024 | 2.962B |
| November 18, 2024 | 2.921B |
| November 15, 2024 | 3.037B |
| November 14, 2024 | 3.183B |
| November 13, 2024 | 3.200B |
| November 12, 2024 | 3.308B |
| November 11, 2024 | 3.360B |
| November 08, 2024 | 3.431B |
| November 07, 2024 | 3.487B |
| November 06, 2024 | 3.426B |
| November 05, 2024 | 3.284B |
| November 04, 2024 | 3.161B |
| Date | Value |
|---|---|
| November 01, 2024 | 3.160B |
| October 31, 2024 | 3.116B |
| October 30, 2024 | 3.175B |
| October 29, 2024 | 3.167B |
| October 28, 2024 | 3.164B |
| October 25, 2024 | 3.163B |
| October 24, 2024 | 3.172B |
| October 23, 2024 | 3.158B |
| October 22, 2024 | 3.239B |
| October 21, 2024 | 3.351B |
| October 18, 2024 | 3.400B |
| October 17, 2024 | 3.283B |
| October 16, 2024 | 3.230B |
| October 15, 2024 | 3.086B |
| October 14, 2024 | 3.165B |
| October 11, 2024 | 3.123B |
| October 10, 2024 | 3.063B |
| October 09, 2024 | 2.988B |
| October 08, 2024 | 3.109B |
| October 07, 2024 | 3.076B |
| October 04, 2024 | 3.087B |
| October 03, 2024 | 3.009B |
| October 02, 2024 | 3.095B |
| October 01, 2024 | 3.061B |
| September 30, 2024 | 2.984B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
282.45M
Minimum
Mar 18 2020
3.772B
Maximum
Feb 09 2024
1.736B
Average
1.794B
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.307B |
| Edesa Biotech Inc | 5.780M |
| Lexaria Bioscience Corp | 42.06M |
| ESSA Pharma Inc | 75.43M |
| ImmunoPrecise Antibodies Ltd | 11.71M |
Market Cap Related Metrics
| PS Ratio | 241.97 |
| PEG Ratio | -1.098 |
| Price to Book Value | 4.018 |
| Price | 42.05 |
| Earnings Yield | -6.71% |
| PEGY Ratio | -1.098 |